Volume 6 Issue 3, Mar 2021

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 6 Issue 3, Mar 2021:
Letter
Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir
Yu Bai,Fei Ye,Yong Feng,Hanyi Liao,Hao Song  ORCID: orcid.org/0000-0002-2811-0370,Jianxun Qi,George Fu Gao  ORCID: orcid.org/0000-0002-3869-615X,Wenjie Tan,Lifeng Fu  ORCID: orcid.org/0000-0003-0431-5424 &…Yi Shi  ORCID: orcid.org/0000-0002-3053-2687